Skip to Content

Metadoxine Approval Status

FDA Approved: No
Generic name: metadoxine
Company: Alcobra Ltd.
Treatment for: ADHD

Metadoxine is an ion-pair salt of pyridoxine (vitamin B6) in development for the treatment of Attention Deficit/Hyperactivity Disorder (ADHD).

Development Status and FDA Approval Process for metadoxine

DateArticle
Jan  9, 2017Alcobra Provides Update on Recent FDA Meeting and Path Forward for MDX Clinical Development Program
Feb  7, 2014Alcobra Announces IND Submission for Extended Release Metadoxine to Treat Adults With ADHD

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide